X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-05 | SDGR | Herman Jenny | CAO | S - Sale | $12.84 | -1,383 | 34,804 | -4% | -$17,764 | |||||
2026-03-05 | SDGR | Jain Rachit | EVP, CFO | S - Sale | $12.90 | -1,631 | 52,596 | -3% | -$21,033 | ||||||
2026-03-05 | SDGR | Tran Yvonne | EVP, CLO, CPO | S - Sale | $12.90 | -1,094 | 52,683 | -2% | -$14,107 | ||||||
2026-03-05 | SDGR | Farid Ramy | Pres, CEO | S - Sale | $12.91 | -3,661 | 330,824 | -1% | -$47,249 | ||||||
2026-03-05 | SDGR | Akinsanya Karen | See Remarks | S - Sale | $12.90 | -1,366 | 69,956 | -2% | -$17,625 | ||||||
2026-03-05 | SDGR | Lorton Kenneth Patrick | EVP, CTO, COO, Software | S - Sale | $12.90 | -1,222 | 89,241 | -1% | -$15,761 | ||||||
2026-03-04 | SDGR | Abel Robert Lorne | See Remarks | S - Sale | $12.81 | -1,300 | 55,897 | -2% | -$16,653 | ||||||
2026-02-10 | SDGR | Tran Yvonne | EVP, CLO, CPO | S - Sale | $13.80 | -776 | 22,859 | -3% | -$10,705 | ||||||
2026-02-10 | SDGR | Lorton Kenneth Patrick | EVP, CTO, COO, Software | S - Sale | $13.73 | -925 | 52,651 | -2% | -$12,704 | ||||||
2026-02-10 | SDGR | Herman Jenny | CAO | S - Sale | $13.79 | -752 | 26,597 | -3% | -$10,370 | ||||||
2026-02-09 | SDGR | Abel Robert Lorne | See Remarks | S - Sale | $13.51 | -1,230 | 19,385 | -6% | -$16,617 | ||||||
2025-10-16 | SDGR | Dugan Margaret | Chief Medical Officer | S - Sale | $21.07 | -1,395 | 24,574 | -5% | -$29,387 | ||||||
| D | 2025-04-14 | SDGR | Akinsanya Karen | Pres of R, D, Therapeutics | S - Sale+OE | $25.09 | -16,723 | 15,625 | -52% | -$419,570 | |||||
2025-03-06 | SDGR | Herman Jenny | SVP, Controller | S - Sale | $21.11 | -666 | 27,349 | -2% | -$14,059 | ||||||
| D | 2025-03-03 | SDGR | Porges Geoffrey Craig | EVP, CFO | S - Sale+OE | $21.76 | -5,491 | 27,544 | -17% | -$119,484 | |||||
| D | 2025-02-18 | SDGR | Tran Yvonne | EVP, CLO, CPO | S - Sale+OE | $28.00 | -3,902 | 11,135 | -26% | -$109,256 | |||||
2025-02-10 | SDGR | Abel Robert Lorne | See Remarks | S - Sale | $25.99 | -1,225 | 8,115 | -13% | -$31,838 | ||||||
2025-02-11 | SDGR | Lorton Kenneth Patrick | EVP, CTO, COO, Software | S - Sale | $24.43 | -985 | 41,076 | -2% | -$24,064 | ||||||
2025-02-11 | SDGR | Herman Jenny | SVP, Controller | S - Sale | $24.43 | -859 | 18,215 | -5% | -$20,985 | ||||||
2025-02-11 | SDGR | Tran Yvonne | EVP, CLO, CPO | S - Sale | $24.43 | -828 | 11,135 | -7% | -$20,228 | ||||||
2024-10-15 | SDGR | Dugan Margaret | Chief Medical Officer | S - Sale | $17.78 | -1,531 | 13,469 | -10% | -$27,226 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |